Beam Therapeutics BEAM Change In Operating Lease Right Of Use Assets
Change In Operating Lease Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept beam:ChangeInOperatingLeaseRightOfUseAssets.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's change in operating lease right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's change in operating lease right of use assets?
- Beam Therapeutics (BEAM) reported change in operating lease right of use assets of $2.53M in Q1 2026.
- How has Beam Therapeutics's change in operating lease right of use assets changed year-over-year?
- Beam Therapeutics's change in operating lease right of use assets decreased by 4.4% year-over-year, from $2.65M to $2.53M.
- What is the long-term trend for Beam Therapeutics's change in operating lease right of use assets?
- Over 4 years (2021 to 2025), Beam Therapeutics's change in operating lease right of use assets has grown at a 3.7% compound annual growth rate (CAGR), from $8.99M to $10.39M.
- What does change in operating lease right of use assets mean?
- Reflects the non-cash adjustment to the balance sheet representing changes in the value of right-of-use assets related to operating leases. This metric is essential for reconciling net income to operating cash flow under current accounting standards. It provides insight into the company's long-term commitment to leased facilities and equipment.